Properly protected IP forms the basis of adequate and widespread communication of lymphangiogenomic’s results by presentation in major scientific meetings and publications in high-ranking scientific journals. This integrated project with more than 40 junior scientists (postdoctoral fellows and graduate students) provides a unique platform for advanced training in all aspects of lymphangiogenesis. This involves techniques in cell and molecular biology, genomics, proteomics, genetics, experimental pathology and bioinformatics, leading to redistribution of specific techniques and providing an intense training platform.

 

 

Participating consortium partners:

 

® Dr. Kari Alitalo, University of Helsinki, Finland

® Dr. Hellmut Augustin, German Cancer Research Center, Heidelberg, Germany

® Dr. Christer Betsholtz, Karolinska Institutet, Stockholm, Sweden

® Dr. Peter Carmeliet, Flancers Interuniversity Institute for Biotechnology, Leuven, Belgium

® Dr. Gerhard Christofori, University of Basel, Switzerland

® Dr. Lena Claesson-Welsh, Uppsala University, Sweden

® Dr. Elisabetta Dejana, IFOM Fondazione Istituto FIRC di Oncologia Moleculare, Milan, Italy

® Dr. Anne Eichmann, Institut National de la Sante et de la Recherche Medicale, Paris, France

® Dr. Mats Hellström, AngioGenetics Sweden AB, Göteborg, Sweden

® Dr. Jyrki Ingman, Lymphatix Ltd., Helsinki, Finland

® Dr. Dontscho Kerjaschki, Medical University of Vienna, Austria

® Dr. Miikka Vikkula, Christian de Duve Institute of Cellular Pathology, Brussels, Belgium

® Dr. Seppo Ylä-Herttuala, University of Kuopio, Finland